Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2010 13:32 ET | Source: FerroKin BioSciences

FerroKin BioSciences Announces Start of a Phase 2 Clinical Trial of FBS0701 as a Novel Treatment for Transfusional Iron Overload

SAN FRANCISCO, Sept. 9, 2010 (GLOBE NEWSWIRE) -- FerroKin BioSciences today announced the initiation of an international Phase 2 study of FBS0701, a novel once-daily iron chelator in development for...
June 17, 2010 11:55 ET | Source: FerroKin BioSciences

FerroKin BioSciences Completes $12 Million Financing

SAN FRANCISCO, June 17, 2010 (GLOBE NEWSWIRE) -- FerroKin BioSciences, a biotechnology company developing a new therapy for the treatment of iron overload, today announced the closing of a $12 million...